Which CT Perfusion Parameter Best Reflects Cerebrovascular Reserve?: Correlation of Acetazolamide-challenged CT Perfusion with Single-photon Emission CT in Moyamoya Patients

Overview

Journal AJNR Am J Neuroradiol

Specialty Neurology

Date 2008 Jul 12

PMID 18617583

Citations 20

Authors

N-J Rim

H S Kim

Y S Shin

S Y Kim

Affiliations

Soon will be listed here.

Abstract

Background And Purpose: CT perfusion (CTP) is a more readily accessible method for evaluation of cerebral perfusion than single-photon emission CT (SPECT). We assessed whether there is any resting or drug-challenged CTP parameter correlating with cerebrovascular reserve (CVR) obtained by SPECT in Moyamoya patients.

Materials And Methods: Normalized baseline CTP parameters and their percentage changes were calculated in 152 regions of interest (ROIs). On qualitative SPECT analysis, each ROI was classified in either the "impaired CVR" or "normal CVR" group. Quantitative CVR was calculated by using normalized SPECT values before and after acetazolamide administration. Baseline CTP parameters and their percentage changes were compared with qualitative and quantitative CVRs. Receiver operating characteristic (ROC) curve analysis defined the threshold values of CTP parameters that best predict impaired qualitative CVR.

Results: The mean values of CTP parameters were significantly different between normal and impaired CVR groups. The percentage change of cerebral blood flow (pcCBF) was correlated most significantly with quantitative CVR (r = 0.89; P < .05). The correlation coefficients between the baseline CTP parameters and quantitative CVR were poor or not significant. The ROC-derived threshold values of pcCBF and mean transit time determined impaired CVR with a sensitivity of 94.4 and 85.2; specificity of 93.2 and 65.9; positive predictive value of 97.1 and 86.0; and negative predictive value of 87.2 and 64.4, respectively.

Conclusion: Baseline CTP parameters are not reliable for predicting impaired CVR. However, pcCBF correlated strongly with quantitative CVR; therefore, CTP evaluation for CVR in Moyamoya patients requires normalization and acetazolamide challenge.

Citing Articles

Advances in moyamoya disease: pathogenesis, diagnosis, and therapeutic interventions.

He S, Zhou Z, Cheng M, Hao X, Chiang T, Wang Y MedComm (2020). 2025; 6(2):e70054.

PMID: 39822761 PMC: 11733107. DOI: 10.1002/mco2.70054.

Risk prediction of postoperative permanent stroke in acute type A aortic dissection patients with severe common carotid artery stenosis using brain CT perfusion.

Li C, Yu J, Shang L, Yang Z, Deng X, An R Heliyon. 2024; 10(17):e36740.

PMID: 39263105 PMC: 11386277. DOI: 10.1016/j.heliyon.2024.e36740.

Qualifying Event and Recurrence of Ischemic Stroke in Symptomatic Artery Occlusion: A Post Hoc Analysis of CMOSS.

Lu G, Wang T, Sun X, Yang R, Luo J, Tong X J Am Heart Assoc. 2024; 13(13):e034056.

PMID: 38934799 PMC: 11255723. DOI: 10.1161/JAHA.123.034056.

Assessment of bypass patency using transcranial Doppler sonography: correlations with computerized tomography angiography findings in patients with moyamoya disease.

Chen J, Ding Y, Li Y, Shi S, Chen J, Tu X Neurosurg Rev. 2023; 46(1):64.

PMID: 36877325 DOI: 10.1007/s10143-023-01970-0.

Predicting PET Cerebrovascular Reserve with Deep Learning by Using Baseline MRI: A Pilot Investigation of a Drug-Free Brain Stress Test.

Chen D, Ishii Y, Fan A, Guo J, Zhao M, Steinberg G Radiology. 2020; 296(3):627-637.

PMID: 32662761 PMC: 7457949. DOI: 10.1148/radiol.2020192793.

References

Schroeder T . Cerebrovascular reactivity to acetazolamide in carotid artery disease. Enhancement of side-to-side CBF asymmetry indicates critically reduced perfusion pressure. Neurol Res. 1986; 8(4):231-6. DOI: 10.1080/01616412.1986.11739760. View

Wintermark M, Maeder P, Thiran J, Schnyder P, Meuli R . Quantitative assessment of regional cerebral blood flows by perfusion CT studies at low injection rates: a critical review of the underlying theoretical models. Eur Radiol. 2001; 11(7):1220-30. DOI: 10.1007/s003300000707. View

Suzuki J, Kodama N . Moyamoya disease--a review. Stroke. 1983; 14(1):104-9. DOI: 10.1161/01.str.14.1.104. View

Yamauchi H, Okazawa H, Sugimoto K, Kishibe Y, Takahashi M . The effect of deafferentation on cerebral blood flow response to acetazolamide. AJNR Am J Neuroradiol. 2004; 25(1):92-6. PMC: 7974156. View

van der Zwan A, Hillen B, Tulleken C, Dujovny M, Dragovic L . Variability of the territories of the major cerebral arteries. J Neurosurg. 1992; 77(6):927-40. DOI: 10.3171/jns.1992.77.6.0927. View

Endo H, Inoue T, Ogasawara K, Fukuda T, Kanbara Y, Ogawa A . Quantitative assessment of cerebral hemodynamics using perfusion-weighted MRI in patients with major cerebral artery occlusive disease: comparison with positron emission tomography. Stroke. 2005; 37(2):388-92. DOI: 10.1161/01.STR.0000199030.37274.88. View

Nariai T, Suzuki R, Hirakawa K, Maehara T, Ishii K, Senda M . Vascular reserve in chronic cerebral ischemia measured by the acetazolamide challenge test: comparison with positron emission tomography. AJNR Am J Neuroradiol. 1995; 16(3):563-70. PMC: 8337663. View

Calamante F, Morup M, Hansen L . Defining a local arterial input function for perfusion MRI using independent component analysis. Magn Reson Med. 2004; 52(4):789-97. DOI: 10.1002/mrm.20227. View

Kaneko K, Kuwabara Y, Mihara F, Yoshiura T, Nakagawa M, Tanaka A . Validation of the CBF, CBV, and MTT values by perfusion MRI in chronic occlusive cerebrovascular disease: a comparison with 15O-PET. Acad Radiol. 2004; 11(5):489-97. DOI: 10.1016/S1076-6332(03)00722-0. View

10.

Eastwood J, Alexander M, Petrella J, Provenzale J . Dynamic CT perfusion imaging with acetazolamide challenge for the preprocedural evaluation of a patient with symptomatic middle cerebral artery occlusive disease. AJNR Am J Neuroradiol. 2002; 23(2):285-7. PMC: 7975256. View

11.

Calamante F, Ganesan V, Kirkham F, Jan W, Chong W, Gadian D . MR perfusion imaging in Moyamoya Syndrome: potential implications for clinical evaluation of occlusive cerebrovascular disease. Stroke. 2001; 32(12):2810-6. DOI: 10.1161/hs1201.099893. View

12.

Kikuchi K, Murase K, Miki H, Yasuhara Y, Sugawara Y, Mochizuki T . Quantitative evaluation of mean transit times obtained with dynamic susceptibility contrast-enhanced MR imaging and with (133)Xe SPECT in occlusive cerebrovascular disease. AJR Am J Roentgenol. 2002; 179(1):229-35. DOI: 10.2214/ajr.179.1.1790229. View

13.

Yamauchi H, Okazawa H, Kishibe Y, Sugimoto K, Takahashi M . Reduced blood flow response to acetazolamide reflects pre-existing vasodilation and decreased oxygen metabolism in major cerebral arterial occlusive disease. Eur J Nucl Med Mol Imaging. 2002; 29(10):1349-56. DOI: 10.1007/s00259-002-0899-x. View

14.

Webster M, Makaroun M, Steed D, Smith H, Johnson D, Yonas H . Compromised cerebral blood flow reactivity is a predictor of stroke in patients with symptomatic carotid artery occlusive disease. J Vasc Surg. 1995; 21(2):338-44; discussion 344-5. DOI: 10.1016/s0741-5214(95)70274-1. View

15.

Togao O, Mihara F, Yoshiura T, Tanaka A, Noguchi T, Kuwabara Y . Cerebral hemodynamics in Moyamoya disease: correlation between perfusion-weighted MR imaging and cerebral angiography. AJNR Am J Neuroradiol. 2006; 27(2):391-7. PMC: 8148755. View

16.

Yamamoto S, Watanabe M, Uematsu T, Takasawa K, Nukata M, Kinoshita N . Correlation of angiographic circulation time and cerebrovascular reserve by acetazolamide-challenged single photon emission CT. AJNR Am J Neuroradiol. 2004; 25(2):242-7. PMC: 7974592. View

17.

Ogasawara K, Ogawa A, Yoshimoto T . Cerebrovascular reactivity to acetazolamide and outcome in patients with symptomatic internal carotid or middle cerebral artery occlusion: a xenon-133 single-photon emission computed tomography study. Stroke. 2002; 33(7):1857-62. DOI: 10.1161/01.str.0000019511.81583.a8. View

18.

Axel L . Tissue mean transit time from dynamic computed tomography by a simple deconvolution technique. Invest Radiol. 1983; 18(1):94-9. DOI: 10.1097/00004424-198301000-00018. View

19.

Chen A, Shyr M, Chen T, Lai H, Lin C, Yen P . Dynamic CT perfusion imaging with acetazolamide challenge for evaluation of patients with unilateral cerebrovascular steno-occlusive disease. AJNR Am J Neuroradiol. 2006; 27(9):1876-81. PMC: 7977914. View

20.

Ozgur H, Walsh T, Masaryk A, Seeger J, Williams W, Krupinski E . Correlation of cerebrovascular reserve as measured by acetazolamide-challenged SPECT with angiographic flow patterns and intra- or extracranial arterial stenosis. AJNR Am J Neuroradiol. 2001; 22(5):928-36. PMC: 8174934. View